A Study of Tafetinib in Chinese Patients With Advanced Solid Tumor
Clinical trial NCT02717741 · UNKNOWN
Trial details
- NCT number
- NCT02717741
- Sponsor
- Nanjing Yoko Biomedical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2017-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.